Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

DM
2019-10-10
DYAIDyadic International IncTchelet RonenVP of Research, Bus. DvlpmtS - Sale+OE$6.06-10,0000-100%-$60,609
2019-10-09
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$3.99+200159,2110%+$798
D
2019-10-08
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$82.47-28,472755,684-4%-$2,348,061
2019-10-07
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale$89.07-25029,592-1%-$22,267
M
2019-10-04
VXRTVaxart, Inc.Armistice Capital, LLC10%P - Purchase$0.36+564,00050,000,000+1%+$203,200
M
2019-10-03
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$3.47+5,700159,011+4%+$19,771
2019-10-02
NBIXNeurocrine Biosciences IncCooke JulieCHROS - Sale$88.56-9873,276-23%-$87,409
2019-10-02
CDTXCidara Therapeutics, Inc.Daruwala PaulCOOS - Sale$1.88-3,29555,872-6%-$6,195
2019-10-01
CDTXCidara Therapeutics, Inc.Abdollahian NeilChief Business OfficerS - Sale$1.98-7,28449,588-13%-$14,422
D
2019-10-01
SGENSeattle Genetics Inc /waGryska David WDirS - Sale+OE$85.09-5,00048,013-9%-$425,450
M
2019-10-01
VXRTVaxart, Inc.Armistice Capital, LLC10%P - Purchase$0.35+436,00048,872,000+1%+$150,552
D
2019-10-02
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$193.58-2,00014,436-12%-$387,160
DM
2019-10-01
TWSTTwist Bioscience CorpWeiss PatrickSVP, R, D GM Data StorageS - Sale+OE$22.86-14,729105,287-12%-$336,689
2019-10-01
TWSTTwist Bioscience CorpPeck BillCTOS - Sale$23.13-20,000663,332-3%-$462,590
D
2019-10-01
VCELVericel CorpColangelo DominickPres, CEOS - Sale+OE$14.88-58,125112,783-34%-$864,650
2019-09-30
SGENSeattle Genetics Inc /waSimpson Todd ECFOS - Sale$85.00-15,000157,567-9%-$1,275,000
2019-09-30
SGENSeattle Genetics Inc /waLiu Jean IGC, EVP, Leg AffairsS - Sale$86.00-7,43270,688-10%-$639,152
2019-09-27
CDTXCidara Therapeutics, Inc.Oien JessicaGC, SecretaryS - Sale$1.86-1,0017,799-11%-$1,862
2019-09-27
PTEPolarityte, Inc.Hague RichardCOOS - Sale$3.56-2,402337,423-1%-$8,551
2019-09-27
PTEPolarityte, Inc.Hoyler Cameron J.GCS - Sale$3.56-281346,6040%-$1,000
M
2019-09-26
VXRTVaxart, Inc.Armistice Capital, LLC10%P - Purchase$0.29+7,333,33348,000,000+18%+$2,143,078
D
2019-09-30
VXRTVaxart, Inc.Latour WouterPres, Chief ExecP - Purchase$0.30+166,667166,667New+$50,000
2019-09-27
ATRAAtara Biotherapeutics, Inc.Newell JoeChief Tech. Operations OfficerS - Sale$13.51-3,50057,998-6%-$47,285
2019-09-25
SGENSeattle Genetics Inc /waDansey Roger DChief Medical OfficerS - Sale$73.80-3,000103,146-3%-$221,415
2019-09-24
CDTXCidara Therapeutics, Inc.Stein JeffreyPres, CEOP - Purchase$1.91+52,500523,648+11%+$100,102
2019-09-24
CDTXCidara Therapeutics, Inc.Levine James E.CFOP - Purchase$1.91+30,000205,000+17%+$57,240
M
2019-09-25
TWSTTwist Bioscience CorpFinn Patrick JohnSVP, Commercial OperationsS - Sale$25.43-37,0005,002-88%-$941,043
2019-09-23
BOLDAudentes Therapeutics, Inc.Lange Louis GDirS - Sale$32.16-11,000326,375-3%-$353,798
2019-09-23
PTEPolarityte, Inc.Hoyler Cameron J.GCS - Sale$4.30-3,500346,885-1%-$15,050
2019-09-23
PTEPolarityte, Inc.Mann Paul ElliotCFOS - Sale$4.30-1,283464,2270%-$5,517
2019-09-23
REPLReplimune Group, Inc.Astley-Sparke PhilipExec COBS - Sale$17.05-14,5001,427,797-1%-$247,225
2019-09-23
REPLReplimune Group, Inc.Love ColinCOOS - Sale$17.05-11,2501,107,774-1%-$191,813
2019-09-23
REPLReplimune Group, Inc.Coffin RobertPres, CEOS - Sale$17.05-24,2502,387,868-1%-$413,463
2019-09-23
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale$21.78-7407,773-9%-$16,117
M
2019-09-20
TCRRTcr2 Therapeutics Inc.Jovan-Embiricos Morana10%S - Sale$17.92-416,3211,605,398-21%-$7,459,819
D
2019-09-20
ALECAlector, Inc.Oney SabahChief Business OfficerS - Sale+OE$20.00-400593,9180%-$8,000
D
2019-09-20
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale+OE$20.00-4,000311,719-1%-$80,000
2019-09-19
VBIVVbi Vaccines Inc.Gillis StevenDirP - Purchase$0.50+10,000,00013,110,473+321%+$5,000,000
D
2019-09-19
RGENRepligen CorpHunt AnthonyCEOS - Sale+OE$82.89-3,600219,413-2%-$298,390
2019-09-18
OTLKOutlook Therapeutics, Inc.Kenyon Lawrence ACEO, Pres, CFO, Treas, SecyS - Sale$1.70-1,35080,863-2%-$2,295
D
2019-09-19
RGNXRegenxbio Inc.Mills Kenneth T.Pres, CEOS - Sale+OE$39.75-10,000241,000-4%-$397,497
D
2019-09-18
CHRSCoherus Biosciences, Inc.Viret Jean-FredericCFOS - Sale+OE$20.44-3,1598,513-27%-$64,560
D
2019-09-17
SWTXSpringworks Therapeutics, Inc.Squinto Stephen PDir, 10%P - Purchase$18.00+275,0007,406,307+4%+$4,950,000
D
2019-09-17
SWTXSpringworks Therapeutics, Inc.Lewis-Hall Freda CDir, 10%P - Purchase$18.00+50,0008,611,092+1%+$900,000
D
2019-09-17
SWTXSpringworks Therapeutics, Inc.Orbimed Advisors LLC10%P - Purchase$18.00+275,0007,406,307+4%+$4,950,000
D
2019-09-17
SWTXSpringworks Therapeutics, Inc.Bain Capital Life Sciences Investors, LLC10%P - Purchase$18.00+150,0007,281,307+2%+$2,700,000
DM
2019-09-17
TWSTTwist Bioscience CorpWeiss PatrickSVP, R, D GM Data StorageS - Sale+OE$29.78-14,728105,287-12%-$438,659
DM
2019-09-16
RUBYRubius Therapeutics, Inc.Carpenter Christopher L.Chief Medical OfficerS - Sale+OE$10.11-48,00034,843-58%-$485,206
DM
2019-09-16
ALLOAllogene Therapeutics, Inc.Moore AlisonChief Technical OfficerS - Sale+OE$32.11-48,82766,067-42%-$1,567,666
2019-09-16
ALECAlector, Inc.Paul RobertChief Medical OfficerS - Sale$19.08-10,000311,719-3%-$190,800
2019-09-17
CVMCel Sci CorpCipriano JohnSVPS - Sale$8.69-8,00083,108-9%-$69,559
M
2019-09-16
TWSTTwist Bioscience CorpBanyai WilliamCOOS - Sale$29.86-22,000703,461-3%-$656,949
2019-09-17
NVAXNovavax IncHerrmann John A IIISVP, GCS - Sale$7.07-3,6430-100%-$25,757
D
2019-09-17
MRNAModerna, Inc.Hutt Peter BartonDirS - Sale+OE$17.63-100,0003,924-96%-$1,763,000
D
2019-09-16
CHRSCoherus Biosciences, Inc.Anicetti Vincent RCOOS - Sale+OE$20.03-2,50019,310-11%-$50,075
2019-09-16
TWSTTwist Bioscience CorpDaniels MarkSVP, GCS - Sale$29.90-1,50051,355-3%-$44,850
M
2019-09-13
TWSTTwist Bioscience CorpPeck BillCTOS - Sale$30.06-19,553683,332-3%-$587,686
2019-09-16
FATEFate Therapeutics IncRedmile Group, LLCDir, 10%P - Purchase$17.50+857,14311,216,809+8%+$15,000,003
2019-09-13
ALDXAldeyra Therapeutics, Inc.Douglas RichardDirP - Purchase$6.00+5,00085,000+6%+$30,000
2019-09-16
BIEIPremier Biomedical IncFelder Mitchell SCOB, 10%P - Purchase$0.01+1,000,0003,334,488+43%+$9,222
D
2019-09-12
RGNXRegenxbio Inc.Christmas Patrick J.SVP, GCS - Sale+OE$42.00-5,4862,572-68%-$230,412
2019-09-13
NVAXNovavax IncGlenn Gregory MPres, R, DS - Sale$6.18-9,620123-99%-$59,476
2019-09-13
NSTGNanostring Technologies IncWaite Charles P JrDirS - Sale$21.75-1,7070-100%-$37,130
2019-09-11
OCXOncocyte CorpLineage Cell Therapeutics, Inc.10%S - Sale$1.66-4,000,0008,424,244-32%-$6,640,000
M
2019-09-11
ALDXAldeyra Therapeutics, Inc.Douglas RichardDirP - Purchase$5.89+20,00080,000+33%+$117,805
D
2019-09-10
DYAIDyadic International IncTchelet RonenVP of Research, Bus. DvlpmtS - Sale+OE$5.27-10,0000-100%-$52,700
2019-09-11
INMBInmune Bio, Inc.Lowdell Mark WilliamChief Scientific Officer, 10%P - Purchase$6.23+2,9181,506,2510%+$18,179
2019-09-11
NVAXNovavax IncTrizzino JohnSVP, CBO, CFOS - Sale$5.72-5,5784,800-54%-$31,911
2019-09-11
BIEIPremier Biomedical IncFelder Mitchell SCOB, 10%P - Purchase$0.01+1,006,4572,334,488+76%+$8,566
2019-09-09
RGENRepligen CorpHunt AnthonyCEOS - Sale$82.40-12,094203,013-6%-$996,521
D
2019-09-09
TECHBio-Techne CorpKummeth Charles R.CEOP - Purchase$185.00+200136,0560%+$37,000
2019-09-09
DNLIDenali Therapeutics Inc.Schuth Alexander O.COO, SecretaryS - Sale$18.16-7,500630,799-1%-$136,200
DM
2019-09-09
BLUEBluebird Bio, Inc.Davidson DavidChief Medical OfficerS - Sale+OE$100.13-5,06031,616-14%-$506,664
M
2019-09-09
ALDXAldeyra Therapeutics, Inc.Douglas RichardDirP - Purchase$5.00+20,00060,000+50%+$99,963
2019-09-10
XLRNAcceleron Pharma IncVeness Adam MVP, GC, Sec.S - Sale$45.20-82416,101-5%-$37,241
2019-09-10
XLRNAcceleron Pharma IncKumar RavindraSVP, Chief Scientific OfficerS - Sale$45.24-3,38986,986-4%-$153,318
2019-09-10
XLRNAcceleron Pharma IncQuisel John DEVP, Chief Business OfficerS - Sale$45.23-3,58459,158-6%-$162,104
2019-09-10
XLRNAcceleron Pharma IncMcLaughlin Kevin FSVP, CFO, TreasurerS - Sale$45.30-8,00022,279-26%-$362,400
2019-09-10
XLRNAcceleron Pharma IncDable Habib JCEO, PresS - Sale$45.23-5,62570,883-7%-$254,412
D
2019-09-09
SGENSeattle Genetics Inc /waSiegall Clay BPres, CEOS - Sale+OE$68.33-28,472755,684-4%-$1,945,531
2019-09-06
ORGOOrganogenesis Holdings Inc.Ades Alan A.Dir, 10%P - Purchase$5.03+10,00067,961,8230%+$50,274
2019-09-09
AERIAerie Pharmaceuticals IncRubino Richard JCFOP - Purchase$19.93+5,040339,446+2%+$100,447
2019-09-09
AERIAerie Pharmaceuticals IncAnido Vicente JrCEOP - Purchase$19.01+26,250197,631+15%+$498,953
D
2019-09-05
BLUEBluebird Bio, Inc.Gregory Philip DChief Scientific OfficerS - Sale+OE$101.20-85029,842-3%-$86,018
M
2019-09-05
NKNantkwest, Inc.Thomas John CDirS - Sale$1.24-24,000383,955-6%-$29,790
M
2019-09-04
AERIAerie Pharmaceuticals IncForesite Capital Management Ii, LLC10%P - Purchase$18.47+115,9002,350,477+5%+$2,140,890
M
2019-09-03
ORGOOrganogenesis Holdings Inc.Ades Alan A.Dir, 10%P - Purchase$4.50+105,10067,951,8230%+$473,209
M
2019-09-03
DNLIDenali Therapeutics Inc.Watts Ryan J.Pres, CEOS - Sale$18.05-8,5812,506,5620%-$154,894
DM
2019-09-03
TWSTTwist Bioscience CorpWeiss PatrickSVP, R, D GM Data StorageS - Sale+OE$27.66-14,728105,287-12%-$407,393
2019-09-03
TWSTTwist Bioscience CorpPeck BillCTOS - Sale$28.43-20,447702,885-3%-$581,210
M
2019-08-21
TCRRTcr2 Therapeutics Inc.Jovan-Embiricos Morana10%S - Sale$17.11-64,1043,507,157-2%-$1,097,080
D
2019-09-03
NBIXNeurocrine Biosciences IncLippoldt DarinGCS - Sale+OE$100.00-6,73620,103-25%-$673,600
D
2019-09-03
SGENSeattle Genetics Inc /waSiegall Clay BSee RemarksS - Sale+OE$70.80-9,693755,684-1%-$686,257
DM
2019-08-30
SGENSeattle Genetics Inc /waHimes Vaughn BSee RemarksS - Sale+OE$72.00-13,692187,518-7%-$985,849
D
2019-09-03
SGENSeattle Genetics Inc /waDansey Roger DSee RemarksS - Sale+OE$70.80-922106,146-1%-$65,277
D
2019-09-03
SGENSeattle Genetics Inc /waLiu Jean ISee RemarksS - Sale+OE$0.00-1,77978,120-2%-$0
D
2019-09-03
SGENSeattle Genetics Inc /waSimpson Todd ESee RemarksS - Sale+OE$70.80-2,092172,567-1%-$148,112
M
2019-08-30
AERIAerie Pharmaceuticals IncForesite Capital Management Ii, LLC10%P - Purchase$21.00+75,0002,325,477+3%+$1,574,741
D
2019-09-04
AMGNAmgen IncSugar Ronald DDirS - Sale+OE$206.70-2,00014,336-12%-$413,400
D
2019-08-30
AMGNAmgen IncPatton Cynthia MSVP, CCOS - Sale+OE$208.07-13,42622,361-38%-$2,793,510
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top